在同情性血管运动控制的选择性损害与上腺素输送体抑制
Jens Tank1, Christoph Schroeder, Andre Diedrich
1Clinical Research Center, Helios Klinikum-Berlin, Franz Volhard Clinic, Medical Faculty of the Charité, Humboldt-University, 13125 Berlin, Germany.
用reboxetine抑制上腺素转运体 (NET) 显著降低了对交感血管运动调的巴罗反射控制. 这种损伤增加了对血管活性药物的敏感性,突出了药物相互作用的新机制.
科学领域:
- 心血管生理学心血管生理学
- 自主神经系统的调节规则
- 药理学 药理学是指药理学的学科.
背景情况:
- 上腺素载体 (NET) 抑制影响了血管活性药物反应和同情反应.
- 这种效应可能源于交感血管运动调节受损.
研究的目的:
- 为了研究选择性NET抑制对心率和交感流量的巴罗反射控制的影响.
- 阐明改变了交感血管运动调节背后的机制.
主要方法:
- 在健康受试者中随机,双盲,交叉研究,使用reboxetine (NET抑制剂) 或安慰剂.
- 测量包括心率,血压和肌肉交感神经活动 (MSNA).
- 通过烯和酸注入评估巴罗反射灵敏度;使用冷压器测试.
主要成果:
- NET抑制显著降低了血压变化所需的血管活性剂剂量.
- 心率的巴罗反射控制是相似的,但重置为更高的血压.
- MSNA和血压振荡在基线和在尼托普鲁塞德输注期间减少.
结论:
- NET抑制有选择性而深刻地降低了对交感血管运动调的巴罗反射控制.
- 这种降低增加了对血管活性药物的敏感性,表明一种新的药物相互作用机制.
更多相关视频
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
08:21Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
相关概念视频
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Drugs Affecting Neurotransmitter Synthesis
